Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (12,698) $ (9,930)
Stock option compensation to employees and directors 4,420 4,422
Stock options issued to consultants 125 221
Common stock issued to consultants 255 92
Amortization of operating lease right-of-use asset 37 46
Change in operating assets and liabilities:    
Receivables 97 (224)
Prepaid expenses and other current assets (23) (775)
Accounts payable 319 (59)
Accrued expenses 176 44
Operating lease liability (43) (46)
Net cash used in operating activities (7,335) (6,209)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (63,770) (44,411)
Proceeds from maturities of short-term investments 68,046 38,809
Net cash provided by (used in) investing activities 4,276 (5,602)
Cash flows from financing activities:    
Proceeds from sale of common stock in an at-the-market offering, net of offering expenses of $168 2,955
Proceeds from sale of common stock pursuant to employee stock purchase plan 10 13
Proceeds from exercise of stock options 456 353
Disbursements for purchases of treasury stock (6)
Net cash provided by financing activities 3,415 366
Net increase (decrease) in cash and cash equivalents 356 (11,445)
Cash and cash equivalents at beginning of year 915 12,360
Cash and cash equivalents at end of year 1,271 915
Supplemental cash flow information:    
Cash proceeds from interest income 1,230 838
Supplemental disclosure of non-cash investing activity:    
Modification to operating lease right-of-use asset (100)
Supplemental disclosure of non-cash financing activity:    
Modification to operating lease liability $ 100